Skip to main content
Erschienen in: Neuroradiology 11/2004

01.11.2004 | Diagnostic Neuroradiology

Sensitivity and reproducibility of a new fast 3D segmentation technique for clinical MR-based brain volumetry in multiple sclerosis

verfasst von: Carsten Lukas, Horst K. Hahn, Barbara Bellenberg, Jan Rexilius, Gebhard Schmid, Sebastian K. Schimrigk, Horst Przuntek, Odo Köster, Heinz-Otto Peitgen

Erschienen in: Neuroradiology | Ausgabe 11/2004

Einloggen, um Zugang zu erhalten

Abstract

Fast, reliable and easy-to-use methods to quantify brain atrophy are of increasing importance in clinical studies on neuro-degenerative diseases. Here, ILAB 4, a new volumetry software that uses a fast semi-automated 3D segmentation of thin-slice T1-weighted 3D MR images based on a modified watershed transform and an automatic histogram analysis was evaluated. It provides the cerebral volumes: whole brain, white matter, gray matter and intracranial cavity. Inter- and intra-rater reliability and scan-rescan reproducibility were excellent in measuring whole brain volumes (coefficients of variation below 0.5%) of volunteers and patients. However, gray and white matter volumes were more susceptible to image quality. High accuracy of the absolute volume results (±5 ml) were shown by phantom and preparation measurements. Analysis times were 6 min for processing of 128 slices. The proposed technique is reliable and highly suitable for quantitative studies of brain atrophy, e.g., in multiple sclerosis.
Fußnoten
1
ILAB4 has been developed in C++ and runs on standard PC hardware (PIII 1GHz, 512 MB RAM) under Microsoft Windows. However, its successor MeVisLAB, will be available for both Windows and Linux. If you are interested in using ILAB and/or the brain volumetry package within a scientific collaboration, please contact MeVis at: Fax. +49-421-2184236, e-mail: ilab4@mevis.de.
 
Literatur
1.
Zurück zum Zitat Rovaris M, Filippi M (1999) Magnetic resonance techniques to monitor disease evolution and treatment trial outcomes in multiple sclerosis. Curr Opin Neurol 12:337–344CrossRefPubMed Rovaris M, Filippi M (1999) Magnetic resonance techniques to monitor disease evolution and treatment trial outcomes in multiple sclerosis. Curr Opin Neurol 12:337–344CrossRefPubMed
2.
Zurück zum Zitat Rovaris M, Comi G, Rocca MA, Wolinsky JS, Filippi M (2001) Short-term brain volume change in relapsing-remitting multiple sclerosis: effect of glatiramer acetate and implications. Brain 124:1803–1812CrossRefPubMed Rovaris M, Comi G, Rocca MA, Wolinsky JS, Filippi M (2001) Short-term brain volume change in relapsing-remitting multiple sclerosis: effect of glatiramer acetate and implications. Brain 124:1803–1812CrossRefPubMed
3.
Zurück zum Zitat Stevenson VL, Leary SM, Losseff NA, Parker GJ, Barker GJ, Husmani Y, Miller DH, Thompson AJ (1998) Spinal cord atrophy and disability in MS: a longitudinal study. Neurology 51:234–238PubMed Stevenson VL, Leary SM, Losseff NA, Parker GJ, Barker GJ, Husmani Y, Miller DH, Thompson AJ (1998) Spinal cord atrophy and disability in MS: a longitudinal study. Neurology 51:234–238PubMed
4.
Zurück zum Zitat Rudick RA, Fisher E, Lee JC, Simon J, Jacobs L (1999) Use of the brain parenchymal fraction to measure whole brain atrophy in relapsing-remitting MS: multiple sclerosis collaborative research group. Neurology 53:1698–1704PubMed Rudick RA, Fisher E, Lee JC, Simon J, Jacobs L (1999) Use of the brain parenchymal fraction to measure whole brain atrophy in relapsing-remitting MS: multiple sclerosis collaborative research group. Neurology 53:1698–1704PubMed
5.
Zurück zum Zitat Losseff NA, Wang L, Lai HM, Yoo DS, Gawne-Cain ML, McDonald WI, Miller DH, Thompson AJ (1996) Progressive cerebral atrophy in multiple sclerosis: a serial MRI study. Brain 119:2009–2019PubMed Losseff NA, Wang L, Lai HM, Yoo DS, Gawne-Cain ML, McDonald WI, Miller DH, Thompson AJ (1996) Progressive cerebral atrophy in multiple sclerosis: a serial MRI study. Brain 119:2009–2019PubMed
6.
Zurück zum Zitat Losseff NA, Webb SL, O’Riordan JI, Page R, Wang L, Barker GJ, Tofts PS, McDonald WI, Miller DH, Thompson AJ (1996) Spinal cord atrophy and disability in multiple sclerosis: a new reproducible and sensitive MRI method with potential to monitor disease progression. Brain 119:701–708PubMed Losseff NA, Webb SL, O’Riordan JI, Page R, Wang L, Barker GJ, Tofts PS, McDonald WI, Miller DH, Thompson AJ (1996) Spinal cord atrophy and disability in multiple sclerosis: a new reproducible and sensitive MRI method with potential to monitor disease progression. Brain 119:701–708PubMed
7.
Zurück zum Zitat Phillips MD, Grossman RI, Miki Y, Wei L, Kolson DL, van Buchem MA, Polansky M, McGowan JC, Udupa JK (1998) Comparison of T2 lesion volume and magnetization transfer ratio histogram analysis and of atrophy and measures of lesion burden in patients with multiple sclerosis. AJNR Am J Neuroradiol 19:1055–1060PubMed Phillips MD, Grossman RI, Miki Y, Wei L, Kolson DL, van Buchem MA, Polansky M, McGowan JC, Udupa JK (1998) Comparison of T2 lesion volume and magnetization transfer ratio histogram analysis and of atrophy and measures of lesion burden in patients with multiple sclerosis. AJNR Am J Neuroradiol 19:1055–1060PubMed
8.
Zurück zum Zitat Edwards SG, Gong QY, Liu C, Zvartau ME, Jaspan T, Roberts N, Blumhardt LD (1999) Infratentorial atrophy on magnetic resonance imaging and disability in multiple sclerosis. Brain 122:291–301CrossRefPubMed Edwards SG, Gong QY, Liu C, Zvartau ME, Jaspan T, Roberts N, Blumhardt LD (1999) Infratentorial atrophy on magnetic resonance imaging and disability in multiple sclerosis. Brain 122:291–301CrossRefPubMed
9.
Zurück zum Zitat Trapp BD, Peterson J, Ransohoff RM, Rudick R, Mork S, Bo L (1998) Axonal transection in the lesions of multiple sclerosis. N Engl J Med 338:278–285CrossRefPubMed Trapp BD, Peterson J, Ransohoff RM, Rudick R, Mork S, Bo L (1998) Axonal transection in the lesions of multiple sclerosis. N Engl J Med 338:278–285CrossRefPubMed
10.
Zurück zum Zitat Lassmann H, Raine CS, Antel J, Prineas JW (1998) Immunopathology of multiple sclerosis: report on an international meeting held at the Institute of Neurology of the University of Vienna. J Neuroimmunol 86:213–217CrossRefPubMed Lassmann H, Raine CS, Antel J, Prineas JW (1998) Immunopathology of multiple sclerosis: report on an international meeting held at the Institute of Neurology of the University of Vienna. J Neuroimmunol 86:213–217CrossRefPubMed
11.
Zurück zum Zitat Silver NC, Barker GJ, Losseff NA, Gawne-Cain ML, MacManus DG, Thompson AJ, Miller DH (1997) Magnetisation transfer ratio measurement in the cervical spinal cord: a preliminary study in multiple sclerosis. Neuroradiology 39:441–445CrossRefPubMed Silver NC, Barker GJ, Losseff NA, Gawne-Cain ML, MacManus DG, Thompson AJ, Miller DH (1997) Magnetisation transfer ratio measurement in the cervical spinal cord: a preliminary study in multiple sclerosis. Neuroradiology 39:441–445CrossRefPubMed
12.
Zurück zum Zitat Silber E, Sharief MK (1999) Axonal degeneration in the pathogenesis of multiple sclerosis. J Neurol Sci 170:11–18CrossRefPubMed Silber E, Sharief MK (1999) Axonal degeneration in the pathogenesis of multiple sclerosis. J Neurol Sci 170:11–18CrossRefPubMed
13.
Zurück zum Zitat Rovaris M, Filippi M, Calori G, Rodegher M, Campi A, Colombo B, Comi G (1997) Intra-observer reproducibility in measuring new putative MR markers of demyelination and axonal loss in multiple sclerosis: a comparison with conventional T2-weighted images. J Neurol 244:266–270CrossRefPubMed Rovaris M, Filippi M, Calori G, Rodegher M, Campi A, Colombo B, Comi G (1997) Intra-observer reproducibility in measuring new putative MR markers of demyelination and axonal loss in multiple sclerosis: a comparison with conventional T2-weighted images. J Neurol 244:266–270CrossRefPubMed
14.
Zurück zum Zitat Matthews PM (1999) Axonal loss and demyelation in multiple sclerosis. J Neurol Neurosurg Psychiatry 67:708–709PubMed Matthews PM (1999) Axonal loss and demyelation in multiple sclerosis. J Neurol Neurosurg Psychiatry 67:708–709PubMed
15.
Zurück zum Zitat Lin X, Blumhardt LD (2001) Inflammation and atrophy in multiple sclerosis: MRI associations with disease course. J Neurol Sci 189:99–104CrossRefPubMed Lin X, Blumhardt LD (2001) Inflammation and atrophy in multiple sclerosis: MRI associations with disease course. J Neurol Sci 189:99–104CrossRefPubMed
16.
Zurück zum Zitat Simon JH, Jacobs LD, Campion MK, Rudick RA, Cookfair DL, Herndon RM, Richert JR, Salazar AM, Fischer JS, Goodkin DE, Simonian N, Lajaunie M, Miller DE, Wende K, Martens-Davidson A, Kinkel RP, Munschauer FE III, Brownscheidle CM (1999) A longitudinal study of brain atrophy in relapsing multiple sclerosis: the multiple sclerosis collaborative research group (MSCRG). Neurology 53:139–148PubMed Simon JH, Jacobs LD, Campion MK, Rudick RA, Cookfair DL, Herndon RM, Richert JR, Salazar AM, Fischer JS, Goodkin DE, Simonian N, Lajaunie M, Miller DE, Wende K, Martens-Davidson A, Kinkel RP, Munschauer FE III, Brownscheidle CM (1999) A longitudinal study of brain atrophy in relapsing multiple sclerosis: the multiple sclerosis collaborative research group (MSCRG). Neurology 53:139–148PubMed
17.
Zurück zum Zitat Nijeholt GJ, van Walderveen MA, Castelijns JA, van Waesberghe JH, Polman C, Scheltens P, Rosier PF, Jongen PJ, Barkhof F (1998) Brain and spinal cord abnormalities in multiple sclerosis: correlation between MRI parameters, clinical subtypes and symptoms. Brain 121:687–697CrossRefPubMed Nijeholt GJ, van Walderveen MA, Castelijns JA, van Waesberghe JH, Polman C, Scheltens P, Rosier PF, Jongen PJ, Barkhof F (1998) Brain and spinal cord abnormalities in multiple sclerosis: correlation between MRI parameters, clinical subtypes and symptoms. Brain 121:687–697CrossRefPubMed
18.
Zurück zum Zitat Lycklama A, Nijeholt GJ, Barkhof F, Scheltens P, Castelijns JA, Ader H, van Waesberghe JH, Polman C, Jongen SJ, Valk J (1997) MR of the spinal cord in multiple sclerosis: relation to clinical subtype and disability. AJNR Am J Neuroradiol 18:1041–1048PubMed Lycklama A, Nijeholt GJ, Barkhof F, Scheltens P, Castelijns JA, Ader H, van Waesberghe JH, Polman C, Jongen SJ, Valk J (1997) MR of the spinal cord in multiple sclerosis: relation to clinical subtype and disability. AJNR Am J Neuroradiol 18:1041–1048PubMed
19.
Zurück zum Zitat Dastidar P, Heinonen T, Lehtimaki T, Ukkonen M, Peltola J, Erila T, Laasonen E, Elovaara I (1999) Volumes of brain atrophy and plaques correlated with neurological disability in secondary progressive multiple sclerosis. J Neurol Sci 165:36–42CrossRefPubMed Dastidar P, Heinonen T, Lehtimaki T, Ukkonen M, Peltola J, Erila T, Laasonen E, Elovaara I (1999) Volumes of brain atrophy and plaques correlated with neurological disability in secondary progressive multiple sclerosis. J Neurol Sci 165:36–42CrossRefPubMed
20.
Zurück zum Zitat Liu C, Edwards S, Gong Q, Roberts N, Blumhardt LD (1999) Three dimensional MRI estimates of brain and spinal cord atrophy in multiple sclerosis. J Neurol Neurosurg Psychiatry 66:323–330PubMed Liu C, Edwards S, Gong Q, Roberts N, Blumhardt LD (1999) Three dimensional MRI estimates of brain and spinal cord atrophy in multiple sclerosis. J Neurol Neurosurg Psychiatry 66:323–330PubMed
21.
Zurück zum Zitat Leist TP, Gobbini MI, Frank JA, McFarland HF (2001) Enhancing magnetic resonance imaging lesions and cerebral atrophy in patients with relapsing multiple sclerosis. Arch Neurol 58:57–60CrossRefPubMed Leist TP, Gobbini MI, Frank JA, McFarland HF (2001) Enhancing magnetic resonance imaging lesions and cerebral atrophy in patients with relapsing multiple sclerosis. Arch Neurol 58:57–60CrossRefPubMed
22.
Zurück zum Zitat Ge Y, Grossman RI, Udupa JK, Babb JS, Nyul LG, Kolson DL (2001) Brain atrophy in relapsing-remitting multiple sclerosis: fractional volumetric analysis of gray matter and white matter. Radiology 220:606–610PubMed Ge Y, Grossman RI, Udupa JK, Babb JS, Nyul LG, Kolson DL (2001) Brain atrophy in relapsing-remitting multiple sclerosis: fractional volumetric analysis of gray matter and white matter. Radiology 220:606–610PubMed
23.
Zurück zum Zitat Chard DT, Griffin CM, Parker GJ, Kapoor R, Thompson AJ, Miller DH (2002) Brain atrophy in clinically early relapsing-remitting multiple sclerosis. Brain 125:327–337CrossRefPubMed Chard DT, Griffin CM, Parker GJ, Kapoor R, Thompson AJ, Miller DH (2002) Brain atrophy in clinically early relapsing-remitting multiple sclerosis. Brain 125:327–337CrossRefPubMed
24.
Zurück zum Zitat De Stefano N, Matthews PM, Filippi M, Agosta F, De Luca M, Bartolozzi ML, Guidi L, Ghezzi A, Montanari E, Cifelli A, Federico A, Smith SM (2003) Evidence of early cortical atrophy in MS: relevance to white matter changes and disability. Neurology 60:1157–1162PubMed De Stefano N, Matthews PM, Filippi M, Agosta F, De Luca M, Bartolozzi ML, Guidi L, Ghezzi A, Montanari E, Cifelli A, Federico A, Smith SM (2003) Evidence of early cortical atrophy in MS: relevance to white matter changes and disability. Neurology 60:1157–1162PubMed
25.
Zurück zum Zitat Quarantelli M, Ciarmiello A, Morra VB, Orefice G, Larobina M, Lanzillo R, Schiavone V, Salvatore E, Alfano B, Brunetti A (2003) Brain tissue volume changes in relapsing-remitting multiple sclerosis: correlation with lesion load. Neuroimage 18:360–366CrossRefPubMed Quarantelli M, Ciarmiello A, Morra VB, Orefice G, Larobina M, Lanzillo R, Schiavone V, Salvatore E, Alfano B, Brunetti A (2003) Brain tissue volume changes in relapsing-remitting multiple sclerosis: correlation with lesion load. Neuroimage 18:360–366CrossRefPubMed
26.
Zurück zum Zitat Miller DH, Barkhof F, Frank JA, Parker GJ, Thompson AJ (2002) Measurement of atrophy in multiple sclerosis: pathological basis, methodological aspects and clinical relevance. Brain 125:1676–1695CrossRefPubMed Miller DH, Barkhof F, Frank JA, Parker GJ, Thompson AJ (2002) Measurement of atrophy in multiple sclerosis: pathological basis, methodological aspects and clinical relevance. Brain 125:1676–1695CrossRefPubMed
27.
Zurück zum Zitat Ge Y, Grossman RI, Babb JS, Rabin ML, Mannon LJ, Kolson DL (2002) Age-related total gray matter and white matter changes in normal adult brain. Part I: volumetric MR imaging analysis. AJNR Am J Neuroradiol 23:1327–33PubMed Ge Y, Grossman RI, Babb JS, Rabin ML, Mannon LJ, Kolson DL (2002) Age-related total gray matter and white matter changes in normal adult brain. Part I: volumetric MR imaging analysis. AJNR Am J Neuroradiol 23:1327–33PubMed
28.
Zurück zum Zitat Courchesne E, Chisum HJ, Townsend J, Cowles A, Covington J, Egaas B, Harwood M, Hinds S, Press GA (2000) Normal brain development and aging: quantitative analysis at in vivo MR imaging in healthy volunteers. Radiology 216:672–682PubMed Courchesne E, Chisum HJ, Townsend J, Cowles A, Covington J, Egaas B, Harwood M, Hinds S, Press GA (2000) Normal brain development and aging: quantitative analysis at in vivo MR imaging in healthy volunteers. Radiology 216:672–682PubMed
29.
Zurück zum Zitat Matthews PM, Pioro E, Narayanan S, De Stefano N, Fu L, Francis G, Antel J, Wolfson C, Arnold DL (1996) Assessment of lesion pathology in multiple sclerosis using quantitative MRI morphometry and magnetic resonance spectroscopy. Brain 119:715–722PubMed Matthews PM, Pioro E, Narayanan S, De Stefano N, Fu L, Francis G, Antel J, Wolfson C, Arnold DL (1996) Assessment of lesion pathology in multiple sclerosis using quantitative MRI morphometry and magnetic resonance spectroscopy. Brain 119:715–722PubMed
30.
Zurück zum Zitat Alfano B, Quarantelli M, Brunetti A, Larobina M, Covelli EM, Tedeschi E, Salvatore M (1998) Reproducibility of intracranial volume measurement by unsupervised multispectral brain segmentation. Magn Reson Med 39:497–499PubMed Alfano B, Quarantelli M, Brunetti A, Larobina M, Covelli EM, Tedeschi E, Salvatore M (1998) Reproducibility of intracranial volume measurement by unsupervised multispectral brain segmentation. Magn Reson Med 39:497–499PubMed
31.
Zurück zum Zitat Filippi M, Mastronardo G, Rocca MA, Pereira C, Comi G (1998) Quantitative volumetric analysis of brain magnetic resonance imaging from patients with multiple sclerosis. J Neurol Sci 158:148–153CrossRefPubMed Filippi M, Mastronardo G, Rocca MA, Pereira C, Comi G (1998) Quantitative volumetric analysis of brain magnetic resonance imaging from patients with multiple sclerosis. J Neurol Sci 158:148–153CrossRefPubMed
32.
Zurück zum Zitat Hahn HK, Peitgen HO, Link F (2003) Concepts for rapid application prototyping in medical image analysis and visualization. In: Proceedings of Simulation und Visualising. SCS, Erlangen, pp 283–298 Hahn HK, Peitgen HO, Link F (2003) Concepts for rapid application prototyping in medical image analysis and visualization. In: Proceedings of Simulation und Visualising. SCS, Erlangen, pp 283–298
33.
Zurück zum Zitat Hahn HK, Peitgen HO (2000) The skull stripping problem in MRI solved by a single 3D watershed transform. In: Proceedings of MICCAI, LNCS 1935. Springer, Berlin Heidelberg New York, pp 134–143 Hahn HK, Peitgen HO (2000) The skull stripping problem in MRI solved by a single 3D watershed transform. In: Proceedings of MICCAI, LNCS 1935. Springer, Berlin Heidelberg New York, pp 134–143
34.
Zurück zum Zitat Hahn HK, Peitgen HO (2003) IWT—interactive watershed transform: a hierachical method for efficient interactive and automated segmentation of multidimensional grayscale images. In: Medical imaging, image processing, proceedings of SPIE 5032:643–653 Hahn HK, Peitgen HO (2003) IWT—interactive watershed transform: a hierachical method for efficient interactive and automated segmentation of multidimensional grayscale images. In: Medical imaging, image processing, proceedings of SPIE 5032:643–653
35.
Zurück zum Zitat Hahn HK, Millar WS, Klinghammer O, Durkin MS, Tulipano PK, Peitgen HO (2004) A reliable and efficient method for cerebral ventricular volumetry in pediatric neuroi-maging. Methods Inf Med 43(4) (in press) Hahn HK, Millar WS, Klinghammer O, Durkin MS, Tulipano PK, Peitgen HO (2004) A reliable and efficient method for cerebral ventricular volumetry in pediatric neuroi-maging. Methods Inf Med 43(4) (in press)
36.
Zurück zum Zitat Blatter DD, Bigler ED, Gale SD, Johnson SC, Anderson CV, Burnett BM, Parker N, Kurth S, Horn SD (1995) Quantitative volumetric analysis of brain MR: normative database spanning 5 decades of life. AJNR Am J Neuroradiol 16:241–251PubMed Blatter DD, Bigler ED, Gale SD, Johnson SC, Anderson CV, Burnett BM, Parker N, Kurth S, Horn SD (1995) Quantitative volumetric analysis of brain MR: normative database spanning 5 decades of life. AJNR Am J Neuroradiol 16:241–251PubMed
37.
Zurück zum Zitat Pfefferbaum A, Mathalon DH, Sullivan EV, Rawles JM, Zipursky RB, Lim KO (1994) A quantitative magnetic resonance imaging study of changes in brain morphology from infancy to late adulthood. Arch Neurol 51:874–87PubMed Pfefferbaum A, Mathalon DH, Sullivan EV, Rawles JM, Zipursky RB, Lim KO (1994) A quantitative magnetic resonance imaging study of changes in brain morphology from infancy to late adulthood. Arch Neurol 51:874–87PubMed
38.
Zurück zum Zitat Hartmann P, Ramseier A, Gudat F, Mihatsch MJ, Polasek W (1994) Normal weight of the brain in adults in relation to age, sex, body height and weight. Pathologe 15:165–170CrossRefPubMed Hartmann P, Ramseier A, Gudat F, Mihatsch MJ, Polasek W (1994) Normal weight of the brain in adults in relation to age, sex, body height and weight. Pathologe 15:165–170CrossRefPubMed
39.
Zurück zum Zitat Ge YGR, Upuda JK et al (2001) Brain atrophy in relapsing multiple sclerosis: relationship to relapses, EDSS, and treatment with interferon beta-1a. Radiology 220:606–610PubMed Ge YGR, Upuda JK et al (2001) Brain atrophy in relapsing multiple sclerosis: relationship to relapses, EDSS, and treatment with interferon beta-1a. Radiology 220:606–610PubMed
40.
Zurück zum Zitat Chard DT, Parker GJ, Griffin CM, Thompson AJ, Miller DH (2002) The reproducibility and sensitivity of brain tissue volume measurements derived from an SPM-based segmentation methodology. J Magn Reson Imaging 15:259–67CrossRefPubMed Chard DT, Parker GJ, Griffin CM, Thompson AJ, Miller DH (2002) The reproducibility and sensitivity of brain tissue volume measurements derived from an SPM-based segmentation methodology. J Magn Reson Imaging 15:259–67CrossRefPubMed
41.
Zurück zum Zitat Stevenson VL, Smith SM, Matthews PM, Miller DH, Thompson AJ (2002) Monitoring disease activity and progression in primary progressive multiple sclerosis using MRI: sub-voxel registration to identify lesion changes and to detect cerebral atrophy. J Neurol 249:171–177PubMed Stevenson VL, Smith SM, Matthews PM, Miller DH, Thompson AJ (2002) Monitoring disease activity and progression in primary progressive multiple sclerosis using MRI: sub-voxel registration to identify lesion changes and to detect cerebral atrophy. J Neurol 249:171–177PubMed
42.
Zurück zum Zitat Ge Y, Grossman RI, Udupa JK, Wei L, Mannon LJ, Polansky M, Kolson DL (2000) Brain atrophy in relapsing-remitting multiple sclerosis and secondary progressive multiple sclerosis: longitudinal quantitative analysis. Radiology 214:665–670PubMed Ge Y, Grossman RI, Udupa JK, Wei L, Mannon LJ, Polansky M, Kolson DL (2000) Brain atrophy in relapsing-remitting multiple sclerosis and secondary progressive multiple sclerosis: longitudinal quantitative analysis. Radiology 214:665–670PubMed
43.
Zurück zum Zitat Fox NC, Jenkins R, Leary SM, Stevenson VL, Losseff NA, Crum WR, Harvey RJ, Rossor MN, Miller DH, Thompson AJ (2000) Progressive cerebral atrophy in MS: a serial study using registered, volumetric MRI. Neurology 54:807–812PubMed Fox NC, Jenkins R, Leary SM, Stevenson VL, Losseff NA, Crum WR, Harvey RJ, Rossor MN, Miller DH, Thompson AJ (2000) Progressive cerebral atrophy in MS: a serial study using registered, volumetric MRI. Neurology 54:807–812PubMed
44.
Zurück zum Zitat Brunetti A, Postiglione A, Tedeschi E, Ciarmiello A, Quarantelli M, Covelli EM, Milan G, Larobina M, Soricelli A, Sodano A, Alfano B (2000) Measurement of global brain atrophy in Alzheimer’s disease with unsupervised segmentation of spin-echo MRI studies. J Magn Reson Imaging 11:260–266CrossRefPubMed Brunetti A, Postiglione A, Tedeschi E, Ciarmiello A, Quarantelli M, Covelli EM, Milan G, Larobina M, Soricelli A, Sodano A, Alfano B (2000) Measurement of global brain atrophy in Alzheimer’s disease with unsupervised segmentation of spin-echo MRI studies. J Magn Reson Imaging 11:260–266CrossRefPubMed
45.
Zurück zum Zitat Whitwell JL, Crum WR, Watt HC, Fox NC (2001) Normalization of cerebral volumes by use of intracranial volume: implications for longitudinal quantitative MR imaging. AJNR Am J Neuroradiol 22:1483–1489PubMed Whitwell JL, Crum WR, Watt HC, Fox NC (2001) Normalization of cerebral volumes by use of intracranial volume: implications for longitudinal quantitative MR imaging. AJNR Am J Neuroradiol 22:1483–1489PubMed
Metadaten
Titel
Sensitivity and reproducibility of a new fast 3D segmentation technique for clinical MR-based brain volumetry in multiple sclerosis
verfasst von
Carsten Lukas
Horst K. Hahn
Barbara Bellenberg
Jan Rexilius
Gebhard Schmid
Sebastian K. Schimrigk
Horst Przuntek
Odo Köster
Heinz-Otto Peitgen
Publikationsdatum
01.11.2004
Erschienen in
Neuroradiology / Ausgabe 11/2004
Print ISSN: 0028-3940
Elektronische ISSN: 1432-1920
DOI
https://doi.org/10.1007/s00234-004-1282-3

Weitere Artikel der Ausgabe 11/2004

Neuroradiology 11/2004 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Schwindelursache: Massagepistole lässt Otholiten tanzen

14.05.2024 Benigner Lagerungsschwindel Nachrichten

Wenn jüngere Menschen über ständig rezidivierenden Lagerungsschwindel klagen, könnte eine Massagepistole der Auslöser sein. In JAMA Otolaryngology warnt ein Team vor der Anwendung hochpotenter Geräte im Bereich des Nackens.

Schützt Olivenöl vor dem Tod durch Demenz?

10.05.2024 Morbus Alzheimer Nachrichten

Konsumieren Menschen täglich 7 Gramm Olivenöl, ist ihr Risiko, an einer Demenz zu sterben, um mehr als ein Viertel reduziert – und dies weitgehend unabhängig von ihrer sonstigen Ernährung. Dafür sprechen Auswertungen zweier großer US-Studien.

Bluttest erkennt Parkinson schon zehn Jahre vor der Diagnose

10.05.2024 Parkinson-Krankheit Nachrichten

Ein Bluttest kann abnorm aggregiertes Alpha-Synuclein bei einigen Menschen schon zehn Jahre vor Beginn der motorischen Parkinsonsymptome nachweisen. Mit einem solchen Test lassen sich möglicherweise Prodromalstadien erfassen und die Betroffenen früher behandeln.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.